Forced degradation of mometasone furoate and development of two RP-HPLC methods for its determination with formoterol fumarate or salicylic acid
Authors:
- Ramzia I. El-BagaryRERamzia I. El-Bagary
- Marwa A. FouadMFMarwa A. Fouad
- Manal A. El-ShalMEManal A. El-Shal
- Enas H. TolbaETEnas H. Tolba
Open Access
- 1 May 2016
- journal article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 9 (3) , 493-505
Abstract
Two simple, selective and precise stability-indicating reversed-phase liquid chromatographic methods were developed and validated for the determination of mometasone furoate in two binary mixtures, with formoterol fumarate (Mixture 1) and salicylic acid (Mixture 2). Also, a forced degradation study of mometasone furoate was carried out including acid and alkali hydrolysis, oxidation, thermal and photo-degradation. For mixture 1, the method was based on isocratic elution using a mobile phase consisting of (Acetonitrile: 3mM Sodium lauryl sulfate) (60:40, v/v) at a flow rate of 1mlmin−1. Quantitation was achieved applying dual wavelength detection where mometasone furoate and its degradation products were detected at 247nm and formoterol fumarate and its degradation product were detected at 214nm at 30°C. For mixture 2 and for the forced degradation study, separation was based on isocratic elution of mometasone furoate, its degradation products and salicylic acid on a reversed phase C8 column using a mobile phase consisting of acetonitrile:water:methanol:glacial acetic acid (60:30:10:0.1, v/v) at a flow rate of 2mLmin−1. Quantitation was achieved with UV detection at 240nm. In addition, products from alkaline forced degradation of mometasone furoate were verified by LC–MS. Linearity, accuracy and precision were found to be acceptable over the concentration range of 10–800μgmL−1 and 5–60μgmL−1 for mometasone furoate and formoterol fumarate, respectively and over the concentration range of 5–320μgmL−1 and 20–1280μgmL−1 for mometasone furoate and salicylic acid, respectively. The two proposed methods could be successfully applied for the routine analysis of the studied drugs in their pharmaceutical preparations without any preliminary separation stepKeywords
This publication has 29 references indexed in Scilit:
- Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysisDrug Testing and Analysis, 2012
- Forced degradation study to develop and validate stability-indicating RP-LC method for the determination of ciclesonide in bulk drug and metered dose inhalersTalanta, 2011
- Validated stability‐indicating derivative and derivative ratio methods for the determination of some drugs used to alleviate respiratory tract disorders and their degradation productsDrug Testing and Analysis, 2011
- Development of a new analytical method for determination of acetylsalicylic and salicylic acids in tablets by reversed phase liquid chromatographyBrazilian Journal of Pharmaceutical Sciences, 2009
- Generic sample preparation and dual polarity liquid chromatography—time‐of‐flight mass spectrometry for high‐throughput screening in doping analysisDrug Testing and Analysis, 2009
- Validation and application of a screening method for β 2‐agonists, anti‐estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006
- High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort TurbuhalerJournal of Pharmaceutical and Biomedical Analysis, 2006
- Cutaneous bioassay of salicylic acid as a keratolyticInternational Journal of Pharmaceutics, 2005
- Determination by HPLC with Electrochemical Detection of Formoterol RR and SS Enantiomers in UrineJournal of Liquid Chromatography & Related Technologies, 1996
- Quantitative determination of the β-adrenoceptor stimulant formoterol in urine by gas chromatography mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1982